Diagnostic and prognostic value of serum albumin for tuberculosis in HIV infected patients eligible for antiretroviral therapy: Datafrom an HIV cohort study in India

BioImpacts

Volumn 3, Issue 3, 2013, Pages 123-128

  Alvarez Uria, Gerardo ^a   Midde, Manoranjan ^a   Pakam, Raghavakalyan ^a   Naik, Praveen Kumar ^a  

^a Rural Development Trust Hospital   (India)

Author keywords

Cost savings; Developing countries; Hypoalbuminemia; India; Mortality; Public health

Indexed keywords

ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ANTIVIRAL THERAPY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPOALBUMINEMIA; INDIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84887347775     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2013.025     Document Type: Article

References (28)

1. World Health Organization. Global tuberculosis control [Internet]. 2012. Available from: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf
2. Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2012;26:2121-33.
3. Alvarez-Uria G, Naik PK, Pakam R, Bachu L, Midde M. Natural history and factors associated with early and delayed mortality in HIV infected patients treated of tuberculosis under directly observed treatment short course (DOTS) strategy: a prospective cohort study in India. Interdiscip Perspect Infect Dis 2012;2012:502012.
4. Bassett IV, Wang B, Chetty S, Giddy J, Losina E, Mazibuko M, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 2010;51:823-9.
5. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings [Internet]. 2011. Available from: http://www.who.int/hiv/pub/tb/9789241500708/en/index.html
6. Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: Individual participant data meta-analysis of observational studies. PLos Med 2011;8: e1000391.
7. World Health Organization. Rapid Implementation of the Xpert MTB/RIF diagnostic test [Internet]. 2011. Available from: http://whqlibdoc.who.int/publications/2011/9789241501569_eng.pdf
8. World Health Organization. Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. Policy Statement [Internet]. 2011. Available from: http://whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf
9. Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R. Rapid diagnosis of pulmonary and extrapulmonary tuberculosis in HIV-infected patients. Comparison of LED fluorescent microscopy and the geneXpert MTB/RIF assay in a district hospital in India. Tuberc Res Treat 2012;2012:932862.
10. Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K, Bassett J, et al. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLos One 2013;8:e65421.
11. Yoon C, Cattamanchi A, Davis JL, Worodria W, den Boon S, Kalema N, et al. Impact of xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda. PLos One 2012;7:e48599.
12. Schutz C, Meintjes G, Almajid F, Wilkinson RJ, Pozniak A. Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J 2010;36:1460-81.
13. Koenig SP, Riviere C, Leger P, Joseph P, Severe P, Parker K, et al. High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clin Infect Dis 2009;48:829-31.
14. Sudfeld CR, Isanaka S, Aboud S, Mugusi FM, Wang M, Chalamilla GE, et al. Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapy. J Infect Dis 2013;207:1370-8.
15. Alvarez-Uria G, Midde M, Pakam R, Naik PK. Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India. Infect Dis Rep 2012;4:e19.
16. Alvarez-Uria G, Midde M, Pakam R, Kannan S, Bachu L, Naik PK. Factors Associated with Late presentation of HIV and estimation of antiretroviral treatment need according to CD4 lymphocyte count in a resource-limited setting: Data from an HIV cohort study in India. Interdiscip Perspect Infect Dis 2012;2012:293795.
17. National AIDS control organisation. Ministry of Health&Family Welfare Government of India. Antiretroviral Therapy Guidelines for HIV infected Adults and Adolescents including Post-exposure. 2007. Available from: http://www.nacoonline.org/About_NACO/Policy__Guidelines/Policies__Guidelines_Table_for_download/
18. Tarantino L, Giorgio A, de Stefano G, Farella N, Perrotta A, Esposito F. Disseminated mycobacterial infection in AIDS patients: abdominal US features and value of fine-needle aspiration biopsy of lymph nodes and spleen. Abdom Imaging 2003;28:602-8.
19. Sharma SK, Smith-Rohrberg D, Tahir M, Mohan A, Seith A. Radiological manifestations of splenic tuberculosis: a 23-patient case series from India. Indian J Med Res 2007;125:669-78.
20. WHO. Treatment of Tuberculosis: guidelines for national programmes. 4th Ed. Geneva: WHO; 2010.
21. Ghate M, Deshpande S, Tripathy S, Nene M, Gedam P, Godbole S, et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis 2009;13:e1-8.
22. Alvarez-Uria G, Reddy R, Reddy S, Naik PK, Midde M. Evaluation of a low-cost strategy for enumerating CD4 lymphocyte absolute count and percentage using the FACSCalibur flow cytometer in HIV-infected patients from a resource-limited setting. ISRN AIDS 2012;2012: 494698.
23. Delong ER, Delong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
24. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. Int J Tuberc Lung Dis 2013;17:636-43.
25. Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, van Cutsem G, Goliath R, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis 2012;55:1698-706.
26. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004;17:432-7.
27. Dao CN, Peters PJ, Kiarie JN, Zulu I, Muiruri P, Ong'ech J, et al. Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women. AIDS Res Hum Retroviruses 2011;27:1149-55.
28. Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, et al. Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients. Int J STD AIDS 2012;23:e1-4.